← Open Payments lookup

ERIC WILKINSON: Open Payments

NPI 1396442232 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,333 in 183 payments from 14 companies in 2025. Trend: 2023 $1,275 · 2024 $1,677 · 2025 $3,333

Food & beverage: $3,333
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.22$740
E.R. Squibb & Sons, L.L.C.26$411
Alkermes, Inc.18$373
Teva Pharmaceuticals USA, Inc.24$372
ABBVIE INC.23$285
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$253
Otsuka America Pharmaceutical, Inc.17$192
Janssen Pharmaceuticals, Inc9$178
Lundbeck LLC9$150
Axsome Therapeutics, Inc.6$115

Products named: INGREZZA, COBENFY, ARISTADA, AUSTEDO XR, VRAYLAR, REXULTI, CAPLYTA, SPRAVATO.

Industry payments across FL — which companies pay providers there.